About Koselugo® (selumetinib) | About this Treatment Option
SponsoredVisit the HCP site to learn about FDA-approved Koselugo as an option for your patients. K…Proven tumor reduction · 66% ORR for NF1 PN · Long-term data available
Types: DOSING, EFFICACY, Prescribing Information, Resources and moreSign Up for NF1-PN Information | NF1-PN HCP Resources
SponsoredLooking for tips to help patients stay engaged with NF1-PN care? Sign up for more info. Vi…Download HCP Resources · NF1-PN HCP Resources · HCP Support · Sign Up for HCP Info

Feedback